Hubert Schoemaker
Hubert Jacob Paul Schoemaker (born March 23, 1950 in Deventer , Netherlands ; † January 1, 2006 in Paoli , Pennsylvania ) was a Dutch -American chemist and biotechnology pioneer.
Hubert Schoemaker was the founder and president of the first US biotech company Centocor , which developed drugs under his leadership, including the chimeric monoclonal antibody infliximab , which is used in the treatment of Crohn's disease and rheumatoid arthritis .
Publications
- BC Delvillano, S. Brennan, P. Brock, C. Bucher, V. Liu, M. mcClure, B. Rake, S. Space, B. Westrick, H. Schoemaker, VR Zurawski: Radioimmunometric Assay for a Monoclonal Antibody-Defined Tumor Markers, CA-19-9 , Clinical Chemistry 39 (1983) 549-552.
- JR Wands, RI Carlson, H. Schoemaker, KJ Isselbacher, VR Zurawski: Immunodiagnosis of Hepatitis-B with High-Affinity IMG Monoclonal Antibodies, Proceedings of the National Academy of Sciences - Biological Sciences 78 (1981) 1214-1218.
Individual evidence
- ↑ Hubert Schoemaker. Biographical summary. In: WhatIsBiotechnology. Retrieved August 8, 2017 .
Web links
- Obituary (Engl.)
- "Pennsylvania Bio Honors Hubert JP Schoemaker with Lifetime Achievement Award" (Engl.)
| personal data | |
|---|---|
| SURNAME | Schoemaker, Hubert |
| ALTERNATIVE NAMES | Schoemaker, Hubert Jacob Paul; Schoemaker, Hubert JP |
| BRIEF DESCRIPTION | American chemist |
| DATE OF BIRTH | March 23, 1950 |
| PLACE OF BIRTH | Deventer |
| DATE OF DEATH | January 1, 2006 |
| Place of death | Paoli |